
BUPROCARE 1MG TABLET
Marketer
Gentech Healthcare Pvt Ltd
Salt Composition
Buprenorphine (1mg)
Overview BUPROCARE 1MG TABLET
Buprenorphine (BUPROCARE 1MG TABLET) is indicated for managing opioid addiction, specifically morphine dependence. It mitigates withdrawal symptoms associated with opioid cessation. Successful treatment often involves a comprehensive approach incorporating counseling and behavioral modifications. Prescription is limited to patients aged 16 and older. As it possesses a potential for dependence, strict adherence to the physician's instructions is crucial. Treatment may incorporate psychosocial support services. This medication can be administered with or without food. Consistent use, as directed by your doctor, is essential for optimal efficacy; missed doses compromise effectiveness. Frequently reported side effects include fatigue, withdrawal symptoms, apprehension, jitters, vertigo, cephalalgia, somnolence, bowel looseness, nausea, emesis, and stomach discomfort. Persistent or worsening side effects warrant immediate medical attention; your physician can offer strategies for symptom management. Prior to commencing treatment, inform your physician of any existing health issues or concurrent medications to ensure safe administration. Pregnant or lactating individuals must seek medical counsel before initiating use.
Uses of BUPROCARE 1MG TABLET
Severe pain management with morphine, indicating opioid dependence.
Major Benefits of BUPROCARE 1MG TABLET:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the BUPROCARE 1MG TABLET whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of BUPROCARE 1MG TABLET:
- Headache
- Drug withdrawal syndrome
- Back pain
- Drowsiness
- Vomiting
- Insomnia (difficulty in sleeping)
- Dizziness
- Abdominal pain
- Weakness
- Sleepiness
- Sweating
- Constipation
- Withdrawal syndrome
- Infection
- Vertigo
- Inflammation of the nose
- Chills
- Flu-like symptoms
- Nausea
How to use BUPROCARE 1MG TABLET:
Administer BUPROCARE 1MG TABLET as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the tablet whole; avoid crushing, chewing, or fracturing. Consumption with or without food is acceptable, though consistent timing is preferred.
How BUPROCARE 1MG TABLET works:
Buprecare 1mg tablets function as a partial opioid agonist, mitigating withdrawal symptoms in individuals discontinuing opioid use by mimicking the effects of these substances.
SAFETY ADVICE
AlcoholUNSAFE
Combining BUPROCARE 1MG TABLETS with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Using BUPROCARE 1MG TABLETS during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of BUPROCARE 1MG TABLETS while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking BUPROCARE 1MG TABLETS may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use BUPROCARE 1MG TABLETS cautiously, potentially requiring dosage modification. Physician consultation is advised.
LiverCAUTION
Patients with liver impairment should use 1mg BUPROCARE tablets cautiously, potentially requiring dosage modification under medical supervision. BUPROCARE 1mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take BUPROCARE 1MG TABLET :
NA
Facts to Know About BUPROCARE 1MG TABLET
| Label | Value |
|---|---|
| Chemical Classification | Phenanthrene Derivatives |
| Developing Habits | Affirmative. |
| Treatment Category | Neuroscience |
| Action Class | Partial Opioid Agonists |
